An innovative service company focusing on the field of drug quality control


Contact Us

You are here:Home >> News >> Company News

Company News

Epilepsy efficacy drugs ——Lacosamide

Time:2024-04-24 Views:10

In our lives, we have long been accustomed to "crazy literature", but another group of people are suffering from "crazy". Epilepsy, a chronic brain disease in which patients may have seizures without warning, is a painful experience for them every time they go crazy. Common medications for epilepsy include Lacosamide.
Lacosamide is an N-methyl-D-aspartate receptor glycine binding site antagonist. Currently, in the synthetic process of synthesizing R-serine and its derivatives as raw materials, impurities are mainly generated in the methylation reaction process, in which impurities are involved in the subsequent reaction, resulting in the derivation of other impurities, mainly amide impurities.
The exact mechanism by which lacosamide exerts its antiepileptic effects in humans has not been fully elucidated. In vitro electrophysiological studies have shown that lacosamide selectively enhances the slow inactivation of voltage-gated sodium channels, thereby stabilizing hyperexcitable neuronal cell membranes and inhibiting recurrent neuronal discharges.
Premier Pharma supplies a full range of EP/USP Lacosamide impurity controls/standards. The following is the catalog of Lacosamide impurity control/standard products (part)
For more details of impurities, please go to the official website:, for more information, please contact:
We are happy to sevice for you.
  • Previous:New Alzheimer‘s drug gets FDA approval for marketing  2024/07/03
  • Next:Engeletin impurity  2024/04/16